Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Leiomyoma 2Stroke 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neuralgia 1Myocardial Infarction 1Liver Neoplasms 1Liver Cirrhosis 1Hot Flashes 1Hemorrhage 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Tranexamic Acid 12Sodium Chloride 4Misoprostol 4Saline Solution 3carbetocin 2Tourniquets 2Oxytocin 2Enoxaparin 2Endoscopic Mucosal Resection 2Dalteparin 2Vitamin B 6 1Vasopressins 1Uterine Artery Embolization 1Ultrasonography 1Tinzaparin 1Thoracic Surgery, Video-Assisted 1Terlipressin 1Sutures 1Surveys and Questionnaires 1Surgicel 1Standard of Care 1Solutions 1Sensitivity Training Groups 1Rivaroxaban 1Ringer's Lactate 1Radiotherapy 1Pancreaticoduodenectomy 1Palliative Care 1Neuromuscular Blockade 1N(4)-oleylcytosine arabinoside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemorrhage × Vitamin B 6 × Clear all
NCT02209545 2023-09-07

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

Northwestern University

Phase 4 Terminated
47 enrolled 4 charts

Hemorrhage, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡